Patent · US Active

Compositions and methods for treating concussion

US10111860B1 · kind B1 · utility

1Cited by
3References
22Claims
0Family size

Inventor

Key dates

Filing dateMay 9, 2017
Grant dateOct 30, 2018
Priority date
Expiry dateMay 9, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/918
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for mitigating a pathology following brain trauma or at least a portion of a cascade of a pathology associated therewith, including compositions and methods for treating concussion or preventing the onset of anecrotic cell death in neurons. Exemplary compositions for treating concussion include an active compound comprising one or more of: phenserine, a phenserine metabolite, a phenserine prodrug, or combinations thereof; and one or more pharmaceutically acceptable excipients. The one or more excipients can be combined with the active compound to form an extended, controlled-release medicament that delivers a therapeutic concentration of the active compound over a period of time. Exemplary methods include administering a therapeutic dose of the active compound and, optionally, a therapeutically acceptable dose of a second active compound, and, optionally, maintaining the therapeutic doses of the active and optional second active compounds at therapeutically effective concentrations over a period of time.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.